Pia Renaudin
Chief Executive Officer bei SCIBASE HOLDING AB (PUBL)
Vermögen: 211 526 $ am 31.03.2024
Profil
Pia Renaudin is currently the Chief Executive Officer at SciBase Holding AB and also holds a Director position at Suturion AB.
Prior to her current roles, she served as the Chief Executive Officer at Senzime AB from 2019 to 2023.
Renaudin received an undergraduate degree from INSEAD and an MBA from the University of Gothenburg in 1992.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SENZIME AB
0,36% | 16.03.2023 | 364 800 ( 0,36% ) | 211 526 $ | 31.03.2024 |
Aktive Positionen von Pia Renaudin
Unternehmen | Position | Beginn |
---|---|---|
SCIBASE HOLDING AB (PUBL) | Chief Executive Officer | 01.10.2023 |
Suturion AB
Suturion AB Miscellaneous Commercial ServicesCommercial Services Suturion AB develops and sells medical technology and equipment specializing on surgery. Its devices help minimize abdominal wall complications; reduce needle prick injuries; and promotes time efficiency and precision. The company was founded by Gabriel Börner and Mats O Christensson in 2018 and is headquartered in Lund, Sweden. | Director/Board Member | - |
Ehemalige bekannte Positionen von Pia Renaudin
Unternehmen | Position | Ende |
---|---|---|
SENZIME AB | Chief Executive Officer | 03.05.2023 |
Ausbildung von Pia Renaudin
INSEAD | Undergraduate Degree |
University of Gothenburg | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SENZIME AB | Health Technology |
SCIBASE HOLDING AB (PUBL) | Health Technology |
Private Unternehmen | 1 |
---|---|
Suturion AB
Suturion AB Miscellaneous Commercial ServicesCommercial Services Suturion AB develops and sells medical technology and equipment specializing on surgery. Its devices help minimize abdominal wall complications; reduce needle prick injuries; and promotes time efficiency and precision. The company was founded by Gabriel Börner and Mats O Christensson in 2018 and is headquartered in Lund, Sweden. | Commercial Services |